Skip to main content

Kiniksa Pharmaceuticals International, plc

KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001730430

In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Kiniksa Pharmaceuticals International, plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
125
+22 vs. Q3 2022
Shares held
30.1M
+429.4K (+1.4%) vs. Q3 2022
Total value
$450.0M
+$69.5M (+18.3%) vs. Q3 2022
New holders
30
41 more added
Sold out
8
35 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KNSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 125 institutions
Q1 2021: 105 institutionsQ2 2021: 102 institutionsQ3 2021: 101 institutionsQ4 2021: 103 institutionsQ1 2022: 96 institutionsQ2 2022: 92 institutionsQ3 2022: 104 institutionsQ4 2022: 125 institutionsQ1 2023: 132 institutionsQ2 2023: 127 institutionsQ3 2023: 134 institutionsQ4 2023: 142 institutionsQ1 2024: 154 institutionsQ2 2024: 133 institutionsQ3 2024: 176 institutionsQ4 2024: 160 institutionsQ1 2025: 176 institutionsQ2 2025: 189 institutionsQ3 2025: 204 institutionsQ4 2025: 224 institutionsQ1 2026: 228 institutionsQ2 2026: 267 institutions
Value heldQ4 2022: $450.0M
Q1 2021: $537.6MQ2 2021: $402.0MQ3 2021: $332.0MQ4 2021: $346.4MQ1 2022: $306.0MQ2 2022: $290.5MQ3 2022: $383.2MQ4 2022: $450.0MQ1 2023: $339.6MQ2 2023: $447.7MQ3 2023: $605.8MQ4 2023: $600.4MQ1 2024: $768.1MQ2 2024: $659.4MQ3 2024: $991.2MQ4 2024: $773.1MQ1 2025: $889.4MQ2 2025: $1.10BQ3 2025: $1.59BQ4 2025: $1.77BQ1 2026: $2.18BQ2 2026: $2.99B
Institutions holding KNSA and their total value by quarter
QuarterHoldersValue
Q2 2026267$2.99B
Q1 2026228$2.18B
Q4 2025224$1.77B
Q3 2025204$1.59B
Q2 2025189$1.10B
Q1 2025176$889.4M
Q4 2024160$773.1M
Q3 2024176$991.2M
Q2 2024133$659.4M
Q1 2024154$768.1M
Q4 2023142$600.4M
Q3 2023134$605.8M
Q2 2023127$447.7M
Q1 2023132$339.6M
Q4 2022125$450.0M
Q3 2022104$383.2M
Q2 202292$290.5M
Q1 202296$306.0M
Q4 2021103$346.4M
Q3 2021101$332.0M
Q2 2021102$402.0M
Q1 2021105$537.6M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Kiniksa Pharmaceuticals International, plc; share changes are against Q3 2022.

Institutions holding KNSA in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
D. E. Shaw & Co., Inc.237,445$3.56M0.01%+125,274+111.7%Added
Hillsdale Investment Management Inc.244,017$3.66M0.31%+244,017New
Lion Point Capital, LP346,500$3.69M2.20%−133,500−27.8%Reduced
Wellington Management Group LLP248,963$3.73M0.00%−18,803−7.0%Reduced
Northern Trust Corp286,675$4.29M0.00%+15,241+5.6%Added
Sphera Funds Management Ltd.307,283$4.60M1.45%+307,283New
Jacobs Levy Equity Management, Inc323,737$4.85M0.03%+6,291+2.0%Added
Ameriprise Financial Inc356,616$5.34M0.00%−17,374−4.6%Reduced
Dimensional Fund Advisors LP392,791$5.88M0.00%−675−0.2%Reduced
Granahan Investment Management Inc504,193$7.55M0.23%−48,157−8.7%Reduced
Geode Capital Management, LLC544,337$8.15M0.00%+20,864+4.0%Added
Hudson Bay Capital Management LP600,000$8.99M0.10%−600,000−50.0%Reduced
Tang Capital Management LLC600,000$8.99M1.31%00.0%Unchanged
Morgan Stanley605,544$9.07M0.00%+110,359+22.3%Added
Rice Hall James & Associates, LLC697,162$10.4M0.60%−52,771−7.0%Reduced
ArrowMark Colorado Holdings LLC717,171$10.7M0.13%−210,923−22.7%Reduced
Millennium Management LLC770,650$11.5M0.01%−172,549−18.3%Reduced
Goldman Sachs Group Inc1,015,908$15.2M0.00%+110,640+12.2%Added
Pictet Asset Management SA1,234,193$18.5M0.03%−1,803,668−59.4%Reduced
State Street Corp1,490,111$22.3M0.00%+878,769+143.7%Added
Rubric Capital Management LP1,569,503$23.5M1.03%+123,396+8.5%Added
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)2,623,924$39.3M0.83%−296,099−10.1%Reduced
Baker Bros. Advisors LP2,799,577$41.9M0.25%00.0%Unchanged
Vanguard Group Inc3,226,891$48.3M0.00%+147,699+4.8%Added
BlackRock Inc.3,581,679$53.7M0.00%−46,781−1.3%Reduced
UBS Oconnor LLC0$00.00%−140,962−100.0%Sold out
Jump Financial, LLC0$00.00%−19,400−100.0%Sold out
XTX Topco Ltd0$00.00%−16,807−100.0%Sold out
Walleye Trading LLC0$00.00%−15,763−100.0%Sold out
Jane Street Group, LLC0$00.00%−11,194−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−10,105−100.0%Sold out
Macquarie Group Ltd0$00.00%−4,020−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−350−100.0%Sold out
Spearhead Capital Advisors, LLC––––Not filed